Skip to main content
FinSpry Logo
FinSpry
STOK logo
STOK
(NASDAQ)
Stoke Therapeutics, Inc.
$29.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Stoke Therapeutics, Inc. (STOK) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Stoke Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy
Based on 9 unique analysts
(12 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$47.86
↑ 61.42% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest STOK Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Joseph Stringer
Needham
BuyMaintains
$40.00
Unknown Analyst
Jefferies
BuyMaintains
$39.00 → $48.00
Marc Goodman
Leerink Partners
BuyMaintains
-
Thomas Shrader
BTIG
BuyMaintains
$39.00
Sumant Kulkarni
Canaccord Genuity
BuyMaintains
$60.00
Laura Chico
Wedbush
BuyMaintains
$38.00
Yatin Suneja
Guggenheim
BuyMaintains
$60.00
Ananda Ghosh
HC Wainwright
BuyMaintains
$50.00
Yaron Werber
TD Cowen
BuyMaintains
-
Joseph Stringer
Needham
BuyMaintains
$40.00
Yatin Suneja
Guggenheim
BuyMaintains
$60.00
Yaron Werber
TD Cowen
BuyMaintains
-

Frequently Asked Questions

What is the analyst consensus rating for STOK?

The analyst consensus rating for STOK is "Buy" based on 9 analyst recommendations.

What is the average price target for STOK?

The average 12-month price target for STOK is $47.86, representing an upside of 61.4% from the current price of $29.65.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.